Company: AstraZeneca PLCBloomberg ticker: AZN LNMarket cap: US$200,088mBackground: AstraZeneca PLC is a science-led biopharmaceutical company. The Company focuses on the discovery, development, and commercialization of prescription medicines in oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal & metabolism, and respiratory and immunology.
 World Class Benchmarking of AstraZeneca

  • Profitable Growth rank of 4 was down compared to the prior period’s 3rd rank
  • This is above average performance compared to 380 large Health Care companies worldwide
  • Profitability rank of 4 was better than its Growth rank of 7
  • Profitability rank of 4 was the same compared to the prior period’s 4th rank
  • This is above average performance compared to peers
  • Growth rank of 7 was down compared to the prior period’s 1st rank
  • This is below average performance compared to peers
  • More By This Author:Asian Stock: Sinopharm Group
    European Stock: Prada SpA
    European Stock: Burberry Group

    Print Friendly, PDF & Email